This week, we’re joined by Dr. Stephen Barnhill (CEO) & Rod Mcllree (Investor and Advisor) from Apollon Formularies, medical cannabis company based in Jamaica.
We investigate Dr. Barnhill’s pioneering research into the use of medical cannabis for cancer, Jamaica’s medical trial and licensing rules, and the influence of the Rastafari on the evolving domestic industry.
→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e119
About Dr. Stephen Barnhill
Dr. Stephen Barnhill is a medical doctor with 35 years’ experience as Chairman and CEO of numerous publicly traded and private companies specializing in laboratory medicine, biotechnology, and pharmaceuticals. He was an early pioneer in the use of artificial intelligence (machine learning) techniques in medicine, primarily in the field of cancer diagnostics.
Dr. Barnhill is an inventor on more than 40 international patents on artificial intelligence and his patents were part of the Intellectual Property portfolio that won MDB Capital’s MICO Award for most disruptive IP portfolio out of 1,600 publicly traded companies. Some of Dr. Barnhill’s early AI patents were acquired by Johnson and Johnson.
About Rod Mcllree
Roderick McIllree is a London based high net worth investor and shareholder in Apollon formularies Plc. He advised and assisted Dr Barnhill and his team on the public listing of the company in April 2021.
Resources
Join Dr. Barnhill on LinkedIn: https://www.linkedin.com/in/stephenbarnhill/?originalSubdomain=uk
Follow Apollon Formularies on LinkedIn: https://www.linkedin.com/company/apollon-formularies/
Visit Apollon Formularies’ Website: https://www.apollon.org.uk/